{"id":"https://openalex.org/W3206934677","doi":"https://doi.org/10.3390/pharmaceutics13101690","title":"Population Pharmacokinetics of Levetiracetam and Dosing Evaluation in Critically Ill Patients with Normal or Augmented Renal Function","display_name":"Population Pharmacokinetics of Levetiracetam and Dosing Evaluation in Critically Ill Patients with Normal or Augmented Renal Function","publication_year":2021,"publication_date":"2021-10-15","ids":{"openalex":"https://openalex.org/W3206934677","doi":"https://doi.org/10.3390/pharmaceutics13101690","mag":"3206934677","pmid":"https://pubmed.ncbi.nlm.nih.gov/34683983","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8540413"},"language":"en","primary_location":{"id":"doi:10.3390/pharmaceutics13101690","doi":"https://doi.org/10.3390/pharmaceutics13101690","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics13101690","pdf_url":"https://www.mdpi.com/1999-4923/13/10/1690/pdf?version=1634280940","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/1999-4923/13/10/1690/pdf?version=1634280940","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059372056","display_name":"Idoia Bilbao Meseguer","orcid":"https://orcid.org/0000-0001-6038-9255","observed_orcids":["https://orcid.org/0000-0001-6038-9255"]},"institutions":[{"id":"https://openalex.org/I169108374","display_name":"University of the Basque Country","ror":"https://ror.org/000xsnr85","country_code":"ES","type":"education","lineage":["https://openalex.org/I169108374"]},{"id":"https://openalex.org/I4210137412","display_name":"Hospital de Cruces","ror":"https://ror.org/03nzegx43","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210125364","https://openalex.org/I4210137412"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Idoia Bilbao-Meseguer","raw_affiliation_strings":["Department of Pharmacy, Cruces University Hospital, Plaza de Cruces 12, 48903 Barakaldo, Spain","Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigaci\u00f3n Lascaray Ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain"],"raw_orcid":"https://orcid.org/0000-0001-6038-9255","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Cruces University Hospital, Plaza de Cruces 12, 48903 Barakaldo, Spain","institution_ids":["https://openalex.org/I4210137412"]},{"raw_affiliation_string":"Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigaci\u00f3n Lascaray Ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain","institution_ids":["https://openalex.org/I169108374"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058499540","display_name":"Helena Barrasa","orcid":"https://orcid.org/0000-0003-2841-6035","observed_orcids":["https://orcid.org/0000-0003-2841-6035"]},"institutions":[{"id":"https://openalex.org/I4210108873","display_name":"Hospital Universitario Araba","ror":"https://ror.org/01zc1f144","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210108873","https://openalex.org/I4210125364"]},{"id":"https://openalex.org/I4210125364","display_name":"Osakidetza","ror":"https://ror.org/02g7qcb42","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210125364"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Helena Barrasa","raw_affiliation_strings":["Instituto de Investigaci\u00f3n Sanitaria Bioaraba, 01009 Vitoria-Gasteiz, Spain","Intensive Care Unit, Araba University Hospital, Osakidetza Basque Health Service, 01009 Vitoria-Gasteiz, Spain"],"raw_orcid":"https://orcid.org/0000-0003-2841-6035","affiliations":[{"raw_affiliation_string":"Instituto de Investigaci\u00f3n Sanitaria Bioaraba, 01009 Vitoria-Gasteiz, Spain","institution_ids":[]},{"raw_affiliation_string":"Intensive Care Unit, Araba University Hospital, Osakidetza Basque Health Service, 01009 Vitoria-Gasteiz, Spain","institution_ids":["https://openalex.org/I4210108873","https://openalex.org/I4210125364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007573955","display_name":"Eduardo As\u00edn\u2010Prieto","orcid":"https://orcid.org/0000-0001-9122-6758","observed_orcids":["https://orcid.org/0000-0001-9122-6758"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I32881790","display_name":"Universit\u00e9 de Poitiers","ror":"https://ror.org/04xhy8q59","country_code":"FR","type":"education","lineage":["https://openalex.org/I32881790"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Eduardo As\u00edn-Prieto","raw_affiliation_strings":["Inserm U1070: Pharmacologie des Anti-Infectieux, P\u00f4le Biologie Sant\u00e9, Universit\u00e9 de Poitiers, B\u00e2timent B36, 1 Rue Georges Bonnet, 86022 Poitiers, France"],"raw_orcid":"https://orcid.org/0000-0001-9122-6758","affiliations":[{"raw_affiliation_string":"Inserm U1070: Pharmacologie des Anti-Infectieux, P\u00f4le Biologie Sant\u00e9, Universit\u00e9 de Poitiers, B\u00e2timent B36, 1 Rue Georges Bonnet, 86022 Poitiers, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I32881790"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083018646","display_name":"Ana Alarcia-Lacalle","orcid":"https://orcid.org/0000-0003-2970-7766","observed_orcids":["https://orcid.org/0000-0003-2970-7766"]},"institutions":[{"id":"https://openalex.org/I169108374","display_name":"University of the Basque Country","ror":"https://ror.org/000xsnr85","country_code":"ES","type":"education","lineage":["https://openalex.org/I169108374"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ana Alarcia-Lacalle","raw_affiliation_strings":["Instituto de Investigaci\u00f3n Sanitaria Bioaraba, Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, 01006 Vitoria-Gasteiz, Spain","Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigaci\u00f3n Lascaray Ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain"],"raw_orcid":"https://orcid.org/0000-0003-2970-7766","affiliations":[{"raw_affiliation_string":"Instituto de Investigaci\u00f3n Sanitaria Bioaraba, Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, 01006 Vitoria-Gasteiz, Spain","institution_ids":[]},{"raw_affiliation_string":"Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigaci\u00f3n Lascaray Ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain","institution_ids":["https://openalex.org/I169108374"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037711682","display_name":"Alicia Rodr\u00edguez\u2010Gasc\u00f3n","orcid":"https://orcid.org/0000-0002-3195-6385","observed_orcids":["https://orcid.org/0000-0002-3195-6385"]},"institutions":[{"id":"https://openalex.org/I169108374","display_name":"University of the Basque Country","ror":"https://ror.org/000xsnr85","country_code":"ES","type":"education","lineage":["https://openalex.org/I169108374"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Alicia Rodr\u00edguez-Gasc\u00f3n","raw_affiliation_strings":["Instituto de Investigaci\u00f3n Sanitaria Bioaraba, Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, 01006 Vitoria-Gasteiz, Spain","Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigaci\u00f3n Lascaray Ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain"],"raw_orcid":"https://orcid.org/0000-0002-3195-6385","affiliations":[{"raw_affiliation_string":"Instituto de Investigaci\u00f3n Sanitaria Bioaraba, Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, 01006 Vitoria-Gasteiz, Spain","institution_ids":[]},{"raw_affiliation_string":"Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigaci\u00f3n Lascaray Ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain","institution_ids":["https://openalex.org/I169108374"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065938149","display_name":"Javier Maynar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108873","display_name":"Hospital Universitario Araba","ror":"https://ror.org/01zc1f144","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210108873","https://openalex.org/I4210125364"]},{"id":"https://openalex.org/I4210125364","display_name":"Osakidetza","ror":"https://ror.org/02g7qcb42","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210125364"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Javier Maynar","raw_affiliation_strings":["Instituto de Investigaci\u00f3n Sanitaria Bioaraba, 01009 Vitoria-Gasteiz, Spain","Intensive Care Unit, Araba University Hospital, Osakidetza Basque Health Service, 01009 Vitoria-Gasteiz, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Investigaci\u00f3n Sanitaria Bioaraba, 01009 Vitoria-Gasteiz, Spain","institution_ids":[]},{"raw_affiliation_string":"Intensive Care Unit, Araba University Hospital, Osakidetza Basque Health Service, 01009 Vitoria-Gasteiz, Spain","institution_ids":["https://openalex.org/I4210108873","https://openalex.org/I4210125364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082245984","display_name":"Jos\u00e9 \u00c1ngel S\u00e1nchez\u2010Izquierdo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 \u00c1ngel S\u00e1nchez-Izquierdo","raw_affiliation_strings":["Intensive Care Unit, Doce de Octubre Hospital, Avda de C\u00f3rdoba, s/n, 28041 Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intensive Care Unit, Doce de Octubre Hospital, Avda de C\u00f3rdoba, s/n, 28041 Madrid, Spain","institution_ids":["https://openalex.org/I4210101691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040516389","display_name":"Goiatz Balziskueta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108873","display_name":"Hospital Universitario Araba","ror":"https://ror.org/01zc1f144","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210108873","https://openalex.org/I4210125364"]},{"id":"https://openalex.org/I4210125364","display_name":"Osakidetza","ror":"https://ror.org/02g7qcb42","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210125364"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Goiatz Balziskueta","raw_affiliation_strings":["Instituto de Investigaci\u00f3n Sanitaria Bioaraba, 01009 Vitoria-Gasteiz, Spain","Intensive Care Unit, Araba University Hospital, Osakidetza Basque Health Service, 01009 Vitoria-Gasteiz, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Investigaci\u00f3n Sanitaria Bioaraba, 01009 Vitoria-Gasteiz, Spain","institution_ids":[]},{"raw_affiliation_string":"Intensive Care Unit, Araba University Hospital, Osakidetza Basque Health Service, 01009 Vitoria-Gasteiz, Spain","institution_ids":["https://openalex.org/I4210108873","https://openalex.org/I4210125364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016527821","display_name":"Mar\u00eda S\u00e1nchez\u2010Bayton Griffith","orcid":"https://orcid.org/0000-0003-3622-9731","observed_orcids":["https://orcid.org/0000-0003-3622-9731"]},"institutions":[{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mar\u00eda S\u00e1nchez-Bayton Griffith","raw_affiliation_strings":["Intensive Care Unit, Doce de Octubre Hospital, Avda de C\u00f3rdoba, s/n, 28041 Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intensive Care Unit, Doce de Octubre Hospital, Avda de C\u00f3rdoba, s/n, 28041 Madrid, Spain","institution_ids":["https://openalex.org/I4210101691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041069734","display_name":"Nerea Qu\u00edlez-Trasobares","orcid":"https://orcid.org/0000-0002-4466-2036","observed_orcids":["https://orcid.org/0000-0002-4466-2036"]},"institutions":[{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Nerea Quilez Trasobares","raw_affiliation_strings":["Intensive Care Unit, Doce de Octubre Hospital, Avda de C\u00f3rdoba, s/n, 28041 Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intensive Care Unit, Doce de Octubre Hospital, Avda de C\u00f3rdoba, s/n, 28041 Madrid, Spain","institution_ids":["https://openalex.org/I4210101691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063259807","display_name":"Maria \u00c1ngel\u00e9s Solin\u00eds","orcid":"https://orcid.org/0000-0001-9127-0775","observed_orcids":["https://orcid.org/0000-0001-9127-0775"]},"institutions":[{"id":"https://openalex.org/I169108374","display_name":"University of the Basque Country","ror":"https://ror.org/000xsnr85","country_code":"ES","type":"education","lineage":["https://openalex.org/I169108374"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Mar\u00eda \u00c1ngeles Solin\u00eds","raw_affiliation_strings":["Instituto de Investigaci\u00f3n Sanitaria Bioaraba, Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, 01006 Vitoria-Gasteiz, Spain","Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigaci\u00f3n Lascaray Ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain"],"raw_orcid":"https://orcid.org/0000-0001-9127-0775","affiliations":[{"raw_affiliation_string":"Instituto de Investigaci\u00f3n Sanitaria Bioaraba, Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, 01006 Vitoria-Gasteiz, Spain","institution_ids":[]},{"raw_affiliation_string":"Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigaci\u00f3n Lascaray Ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain","institution_ids":["https://openalex.org/I169108374"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015256484","display_name":"Arantxa Isla","orcid":"https://orcid.org/0000-0001-7575-2715","observed_orcids":["https://orcid.org/0000-0001-7575-2715"]},"institutions":[{"id":"https://openalex.org/I169108374","display_name":"University of the Basque Country","ror":"https://ror.org/000xsnr85","country_code":"ES","type":"education","lineage":["https://openalex.org/I169108374"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Arantxa Isla","raw_affiliation_strings":["Instituto de Investigaci\u00f3n Sanitaria Bioaraba, Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, 01006 Vitoria-Gasteiz, Spain","Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigaci\u00f3n Lascaray Ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain"],"raw_orcid":"https://orcid.org/0000-0001-7575-2715","affiliations":[{"raw_affiliation_string":"Instituto de Investigaci\u00f3n Sanitaria Bioaraba, Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, 01006 Vitoria-Gasteiz, Spain","institution_ids":[]},{"raw_affiliation_string":"Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigaci\u00f3n Lascaray Ikergunea, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain","institution_ids":["https://openalex.org/I169108374"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5015256484","https://openalex.org/A5063259807"],"corresponding_institution_ids":["https://openalex.org/I169108374"],"apc_list":{"value":2200,"currency":"CHF","value_usd":2376},"apc_paid":{"value":2200,"currency":"CHF","value_usd":2376},"fwci":1.6763,"has_fulltext":true,"cited_by_count":31,"citation_normalized_percentile":{"value":0.80659871,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"13","issue":"10","first_page":"1690","last_page":"1690"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.7612000107765198,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.7612000107765198,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.12229999899864197,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.07739999890327454,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/levetiracetam","display_name":"levetiracetam","score":1.0},{"id":"https://openalex.org/keywords/population-pharmacokinetics","display_name":"population pharmacokinetics","score":0.9860000014305115},{"id":"https://openalex.org/keywords/critically-ill-patients","display_name":"critically ill patients","score":0.7440000176429749},{"id":"https://openalex.org/keywords/augmented-renal-clearance","display_name":"augmented renal clearance","score":0.8560000061988831},{"id":"https://openalex.org/keywords/dose-optimization","display_name":"dose optimization","score":0.4860000014305115},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.8360000252723694},{"id":"https://openalex.org/keywords/intensive-care-unit","display_name":"intensive care unit","score":0.7279999852180481},{"id":"https://openalex.org/keywords/creatinine-clearance","display_name":"creatinine clearance","score":0.8159999847412109},{"id":"https://openalex.org/keywords/two-compartment-model","display_name":"two-compartment model","score":0.8029999732971191},{"id":"https://openalex.org/keywords/inter-individual-variability","display_name":"interindividual variability","score":0.9079999923706055},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.4189999997615814}],"concepts":[{"id":"https://openalex.org/C2777332695","wikidata":"https://www.wikidata.org/wiki/Q417227","display_name":"Levetiracetam","level":3,"score":0.9283187389373779},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7562617659568787},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.6720364093780518},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.6506452560424805},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6183459162712097},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5425229072570801},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.511127769947052},{"id":"https://openalex.org/C2987404301","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care","level":2,"score":0.4682014584541321},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.43623408675193787},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.42196232080459595},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.37963148951530457},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2960634231567383},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.28389328718185425},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.11420470476150513},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.3390/pharmaceutics13101690","doi":"https://doi.org/10.3390/pharmaceutics13101690","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics13101690","pdf_url":"https://www.mdpi.com/1999-4923/13/10/1690/pdf?version=1634280940","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:34683983","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34683983","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8540413","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8540413/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"Text"},{"id":"pmh:oai:addi.ehu.eus:10810/53642","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10810/53642","pdf_url":null,"source":{"id":"https://openalex.org/S4306401964","display_name":"Communities in ADDI (University of the Basque Country)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169108374","host_organization_name":"University of the Basque Country","host_organization_lineage":["https://openalex.org/I169108374"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:14f21efc86af4fcf81a42c7ab4b84e1c","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/14f21efc86af4fcf81a42c7ab4b84e1c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceutics, Vol 13, Iss 10, p 1690 (2021)","raw_type":"article"},{"id":"pmh:oai:hispana.mcu.es:60860556","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10810/53642","pdf_url":null,"source":{"id":"https://openalex.org/S4377196108","display_name":"Hispana","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.3390/pharmaceutics13101690","doi":"https://doi.org/10.3390/pharmaceutics13101690","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics13101690","pdf_url":"https://www.mdpi.com/1999-4923/13/10/1690/pdf?version=1634280940","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G2299828610","display_name":null,"funder_award_id":"PIBA 2019-57","funder_id":"https://openalex.org/F4320321705","funder_display_name":"Eusko Jaurlaritza"},{"id":"https://openalex.org/G3907863029","display_name":null,"funder_award_id":"PIFG19/23","funder_id":"https://openalex.org/F4320321919","funder_display_name":"Euskal Herriko Unibertsitatea"},{"id":"https://openalex.org/G394274785","display_name":null,"funder_award_id":"GIU20/048","funder_id":"https://openalex.org/F4320321919","funder_display_name":"Euskal Herriko Unibertsitatea"},{"id":"https://openalex.org/G5378419377","display_name":null,"funder_award_id":"GIU20/048","funder_id":"https://openalex.org/F4320321705","funder_display_name":"Eusko Jaurlaritza"},{"id":"https://openalex.org/G919784985","display_name":null,"funder_award_id":"GIU 17/32","funder_id":"https://openalex.org/F4320321919","funder_display_name":"Euskal Herriko Unibertsitatea"}],"funders":[{"id":"https://openalex.org/F4320321705","display_name":"Eusko Jaurlaritza","ror":"https://ror.org/00pz2fp31"},{"id":"https://openalex.org/F4320321919","display_name":"Euskal Herriko Unibertsitatea","ror":"https://ror.org/000xsnr85"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3206934677.pdf","grobid_xml":"https://content.openalex.org/works/W3206934677.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1989887789","https://openalex.org/W1996896888","https://openalex.org/W2043573030","https://openalex.org/W2059213454","https://openalex.org/W2059776387","https://openalex.org/W2060587811","https://openalex.org/W2069789486","https://openalex.org/W2124431328","https://openalex.org/W2143069698","https://openalex.org/W2149974939","https://openalex.org/W2163232559","https://openalex.org/W2252496421","https://openalex.org/W2754662782","https://openalex.org/W2786832455","https://openalex.org/W2788348875","https://openalex.org/W2885322963","https://openalex.org/W2890474169","https://openalex.org/W2891797502","https://openalex.org/W2896030168","https://openalex.org/W2913445675","https://openalex.org/W2922074526","https://openalex.org/W3006742852","https://openalex.org/W3007019480","https://openalex.org/W3121047679","https://openalex.org/W3133016819","https://openalex.org/W3155658141"],"related_works":["https://openalex.org/W7128907794","https://openalex.org/W3155658141","https://openalex.org/W4224261270","https://openalex.org/W4414004686","https://openalex.org/W4400653691","https://openalex.org/W4210387984","https://openalex.org/W3177711729","https://openalex.org/W4407758778","https://openalex.org/W4407898515","https://openalex.org/W4385274271"],"abstract_inverted_index":{"Levetiracetam":[0,67],"is":[1,18],"a":[2,74],"broad-spectrum":[3],"antiepileptic":[4],"drug":[5],"commonly":[6],"used":[7],"in":[8,26,154,171],"intensive":[9],"care":[10],"units":[11],"(ICUs).":[12],"The":[13,77,126],"objective":[14],"of":[15,23,93,107,138,190],"this":[16],"study":[17,47],"to":[19,36],"evaluate":[20],"the":[21,37,117,136],"adequacy":[22],"levetiracetam":[24,64,184],"dosing":[25],"patients":[27,52,155,172,177],"with":[28,53,63,156,173,178,183],"normal":[29,157,179],"or":[30,146,163,180],"augmented":[31],"renal":[32,158],"clearance":[33,56,86,100],"(ARC)":[34],"admitted":[35],"ICU":[38],"by":[39,73],"population":[40],"modelling":[41],"and":[42,61,80,104],"simulation.":[43],"A":[44],"multicentre":[45],"prospective":[46],"including":[48],"twenty-seven":[49],"critically":[50],"ill":[51,176],"urinary":[54],"creatinine":[55],"(CrCl)":[57],">":[58],"50":[59],"mL/min":[60],"treated":[62,182],"was":[65],"developed.":[66],"plasma":[68],"concentrations":[69],"were":[70,85],"best":[71],"described":[72],"two-compartment":[75],"model.":[76],"parameter":[78],"estimates":[79,114],"relative":[81],"standard":[82],"errors":[83],"(%)":[84],"(CL)":[87],"3.5":[88],"L/h":[89,102],"(9%),":[90],"central":[91],"volume":[92,106],"distribution":[94,108],"(V1)":[95],"20.7":[96],"L":[97,110],"(18%),":[98],"intercompartmental":[99],"31.9":[101],"(22%),":[103],"peripheral":[105],"33.5":[109],"(13%).":[111],"Interindividual":[112],"variability":[113],"were,":[115],"for":[116,122],"CL,":[118],"32.7%":[119],"(21%)":[120],"and,":[121],"V1,":[123],"56.1%":[124],"(29%).":[125],"CrCl":[127],"showed":[128,134],"significant":[129],"influence":[130],"over":[131],"CL.":[132],"Simulations":[133],"that":[135],"administration":[137],"at":[139,187],"least":[140],"500":[141],"mg":[142,148],"every":[143,149,166],"8":[144,167],"h":[145,151],"1000":[147],"12":[150],"are":[152,169],"needed":[153,170],"function.":[159],"Higher":[160],"doses":[161],"(1500":[162],"2000":[164],"mg,":[165],"h)":[168],"ARC.":[174],"Critically":[175],"ARC":[181],"could":[185],"be":[186],"high":[188],"risk":[189],"being":[191],"underdosed.":[192]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2021-10-25T00:00:00"}